Phase I/II study of AGI-134 for the treatment of solid tumours
Phase of Trial: Phase I/II
Latest Information Update: 06 Mar 2018
At a glance
- Drugs AGI 134 (Primary)
- Indications Solid tumours
- Focus Adverse reactions; First in man; Therapeutic Use
- 06 Mar 2018 According to a BioLineRx media release, this trial is expected to start in mid-2018.
- 23 Mar 2017 According to a BioLineRx media release, this trial is expected to start in the first half of 2018.
- 24 Jan 2017 New trial record